Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 27, 2026

A Teleoperated Robotic System-Assisted Percutaneous Transiliac-Transsacral Screw Fixation Technique
05:57

A Teleoperated Robotic System-Assisted Percutaneous Transiliac-Transsacral Screw Fixation Technique

Published on: January 6, 2023

Robotic technology in surgery: current status in 2008.

Declan G Murphy1, Rohan Hall, Raymond Tong

  • 1Department of Urology, Epworth Hospital, Richmond, Victoria, Australia. decmurphy@doctors.net.uk

ANZ Journal of Surgery
|December 18, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and implementation of the IMRA multiplatform Foundations in Robotic Surgery online learning curriculum.

Journal of robotic surgery·2026
Same author

Implantable pelvic neurostimulators to restore erectile function: from concept to practice.

Nature reviews. Urology·2026
Same author

Pelvic Lymph Node Dissection in Prostate Cancer: Is It Really Necessary? A Multicentric Longitudinal Study Assessing Oncological Outcomes in Patients With Prostate Cancer Undergoing Pelvic Lymph Node Dissection vs Radical Prostatectomy Only.

The Journal of urology·2025
Same author

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Cancer discovery·2025
Same author

Re: [<sup>177</sup>Lu]Lu-PSMA-617 plus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer (ENZA-p): An Open-label, Multicentre, Randomised, Phase 2 Trial.

European urology·2024
Same author

Re: Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening. The STHLM3-MRI Randomized Clinical Trial.

European urology·2024
Same journal

Virtual Care of Acute Diverticulitis: A Phase I/II Randomised Clinical Feasibility Trial.

ANZ journal of surgery·2026
Same journal

Intrathyroid Parathyroid Adenoma Appearance on FCH PET/CT Imaging.

ANZ journal of surgery·2026
Same journal

The Rising Demand of Emergency General Surgery: A 15-Year Study at a Metropolitan New Zealand Hospital.

ANZ journal of surgery·2026
Same journal

Changing Aetiology of Perforated Peptic Ulcers: Rising Impact of Non-Steroidal Anti-Inflammatories in Western Australia.

ANZ journal of surgery·2026
Same journal

The Role of Non-Technical Errors in Hip Fracture Mortality: A National Retrospective Cohort Study.

ANZ journal of surgery·2026
Same journal

When Early Cholecystectomy Outpaces Capacity: Post-Decision Delay, Population Growth and Six Service Solutions From a Regional Australian Cohort Study.

ANZ journal of surgery·2026
See all related articles

Robotic-assisted surgery using the da Vinci system is increasingly adopted in Australia and New Zealand, primarily for urological procedures. While safe and feasible, high costs limit its availability, especially for public patients.

Area of Science:

  • Minimally Invasive Surgery
  • Surgical Technology
  • Robotics in Medicine

Background:

  • Growing interest in robotic-assisted surgery (RAS) globally, driven by systems like da Vinci.
  • Debate exists regarding the utility and cost-effectiveness of current robotic surgical technology.
  • The da Vinci surgical system is increasingly available in Australia and New Zealand.

Purpose of the Study:

  • To describe current robotic surgical technology.
  • To review published data on the da Vinci system.
  • To assess the status of surgical robotics in Australia and New Zealand.

Main Methods:

  • Review of published literature on robotic-assisted surgery.
  • Assessment of da Vinci system installation and usage data in Australia and New Zealand.

More Related Videos

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
07:27

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection

Published on: February 7, 2025

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

Related Experiment Videos

Last Updated: Jun 27, 2026

A Teleoperated Robotic System-Assisted Percutaneous Transiliac-Transsacral Screw Fixation Technique
05:57

A Teleoperated Robotic System-Assisted Percutaneous Transiliac-Transsacral Screw Fixation Technique

Published on: January 6, 2023

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
07:27

Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection

Published on: February 7, 2025

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision
07:22

Surgical Robot-Assisted Transanal Specimen Extraction Radical Sigmoidectomy Without an Auxiliary Abdominal Incision

Published on: June 13, 2025

  • Analysis of procedures performed and their feasibility and safety.

    • Main Results:

    • Seven da Vinci systems are in use in Australia and New Zealand, mostly in private hospitals.
    • Robotic-assisted surgery adoption has increased fivefold in four years, with urological procedures dominating.
    • Robotic-assisted laparoscopic radical prostatectomy is the most common procedure.
    • Robotic-assisted surgery is feasible and safe, but installation and recurring costs are high.
    • Acceptance is growing, particularly for urological procedures.

    Conclusions:

    • Robotic-assisted surgery is feasible and safe, with increasing acceptance in Australia and New Zealand.
    • The da Vinci system's availability is expanding, with potential for broader specialty use.
    • High costs remain a significant barrier, limiting accessibility for public patients.